PharmCADD Companies
PharmCADD uses AI-based protein structure prediction algorithms, MD simulation, and quantum calculation to enable faster drug design.
.jpg)
Last Funding Type:
Series B
Funding Status:
Early Stage Venture
Headquarters:
Busan, Pusan-jikhalsi, South Korea
Founded Date:
2019-03-05
Investor Type:
For Profit
Last Funding Date:
2021-04-19
Total Funding:
16000000.0
Technology:
Artificial Intelligence, Biotechnology, Pharmaceutical
Employee Number:
11-50
Investors Number:
6.0
Industry:
BioTech & Health Care